Multicellular origin of tenascin in skin tumors - An in situ hybridization study

Journal of Cutaneous Pathology

Volumn 24, Issue 10, 1997, Pages 590-596

  Tuominen, Hannu ^a,b,c   Pöllänen, Raimo ^a   Kallioinen, Matti ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b Keski Pohjanmaan Erikoissairaanhoito Ja Peruspalvelukuntayhtyma   (Finland)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TENASCIN;

ARTICLE; BASAL CELL CARCINOMA; CONTROLLED STUDY; EPIDERMIS; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; KERATINOCYTE; MELANOCYTIC NEVUS; MELANOMA; PRECANCER; PROTEIN SYNTHESIS; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; STROMA;

EID: 0030690483     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1997.tb01089.x     Document Type: Article

References (39)

1. Chiquet M, Fambrough DM. Chick myotendinous antigen. 1. A monoclonal antibody as a marker for tendon and muscle morphogenesis. J Cell Biol 1984: 98: 1296.
2. Koukoulis GK, Gould VE, Bhattacharyya A, Gould JE, Howeedy AA, Virtanen I. Tenascin in normal, reactive, hyperplastic and neoplastic tissues. Hum Pathol 1991: 22: 636.
3. Howeedy AA, Virtanen I, Laitinen L, Gould NS, Koukoulis GK, Gould VE. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast. Lab Invest 1990: 63: 798.
4. Sasano H, Nagura H, Watanabe K et al. Tenascin expression in normal and abnormal human endometrium. Mod Pathol 1993: 6: 323.
5. Chiquet-Ehrismann R, Mackie EJ, Pearson CA, Sakakura T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 1986: 47: 131.
6. Soini Y, Alavaikko M, Lehto VP, Virtanen I. Tenascin in reactive lymph nodes and in malignant lymphomas. Pathol Res Pract 1992: 8: 1078.
7. Lightner VA, Gumkowski F, Bigner DD, Erickson HP. Tenascin/hexabrachion in human skin: biochemical identification and localization by light and electron microscopy. J Cell Biol 1989: 108: 2483.
8. Tuominen H, Kallioinen M. Increased tenascin expression in melanocytic tumors. J Cutan Pathol 1994: 31: 424.
9. Schalkwijk J, van Vlijmen I, Oosterling B et al. Tenascin expression in hyperproliferative skin diseases. Br J Dermatol 1991: 124: 13.
10. Mackie EJ, Hafter W, Liverani D. Induction of tenascin in healing wounds. J Cell Biol 1988: 107: 2757.
11. Stamp GWH. Tenascin distribution in basal cell carcinomas. J Pathol 1989: 159: 225.
12. Anbazhagan R, Sakakura T, Gusterson BA. The distribution of immuno-reactive tenascin in the epithelial-mesenchymal junctional areas of benign and malignant squamous epithelia. Virch Arch B Cell Pathol 1990: 59: 59.
13. Herlyn M, Graeven U, Speicher D et al. Characterization of tenascin secreted by human melanoma cells. Cancer Res 1991: 51: 4853.
14. Erickson H, Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. Curr Opin Cell Biol 1993: 5: 869.
15. Lightner VA. Tenascin: Does it play a role in epidermal morphogenesis and homeostasis? J Invest Dermatol 1994: 102: 273.
16. Spring J, Beck K, Chiquet-Ehrismann R. Two contrary functions of tenascin: dissection of the active sites by recombinant tenascin fragments. Cell 1989: 59: 325.
17. Kallioinen M, Sandberg M, Palatsi R, Oikarinen A. Sarcoidosis of the skin: an immunohistochemical and in situ hybridization study of collagen synthesis and cellular subsets. Eur J Dermatol 1992: 2: 293.
18. Chicquet-Ehrismann R. Anti-adhesive molecules of the extracellular matrix. Curr Opin Cell Biol 1991: 3: 800.
19. Chiquet-Ehrishmann R, Kalla P, Pearson CA, Beck K, Chiquet M. Tenascin interferes with fibronectin action. Cell 1988: 53: 383.
20. Erickson HP, Bourdon MA. Tenascin, an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Ann Rev Cell Biol 1989: 5: 71.
21. Erickson HP. Gene knockouts of c-src, transforming growth factor β1, and tenascin suggest superfluous, non-functional expression of proteins. J Cell Biol 1993: 120: 1079.
22. Saga Y, Vagi T, Ikawa Y, Sakakura T, Aizawa S. Mice develop normally without tenascin. Genes Dev 1992: 6: 1821.
23. Lightner VA, Marks JR, McCachren SS. Epithelial cells are an important source of tenascin in normal and malignant human breast tissue. Exp Cell Res 1994: 210: 177.
24. McCachren SS, Lightner VA. Expression of human tenascin in synovitis and its regulation by interleukin-1. Arthritis Rheum 1992: 35: 1185.
25. Yoshida T, Ishihara A, Horokawa Y, Kusakabe M, Sakakura T. Tenascin in breast cancer development - is epithelial tenascin a marker for poor prognosis? Cancer Lett 1995: 90: 65.
26. Tucker RP, Moiseiwitsch JRD, Lauder JM. In situ localization of tenascin mRNA in developing mouse teeth. Arch Oral Biol 1993: 38: 1025.
27. Tsukamoto T, Kusakabe M, Saga Y. In situ hybridization with non-radioactive digoxigenin-11-UTP-labeled cRNA probes: localization of developmentally regulated mouse tenascin mRNAs. Int J Dev Biol 1991: 35: 25.
28. Tucker RP, McKay S. The expression of tenascin by neural crest cells and glia. Development 1991: 112: 1031.
29. Mackie EJ, Tucker RP. Tenascin in bone morphogenesis: expression by osteoblasts and cell type-specific expression of splice variants. J Cell Sci 1992: 103: 765.
30. Lever WK, Schaumburg-Lever G. Histopathology of the Skin. 7th edn. Philadelphia: J. B. Lippincott Company, 1990: 756.
31. Siri A, Carnemolla B, Saginati M et al. Human tenascin: primary structure, pre-mRNA splicing patterns and localization of the epitopes recognized by two monoclonal antibodies. Nucl Acids Res 1991: 19: 525.
32. Hogan B, Constantini K, Lacy E. Manipulation of the mouse embryo. A laboratory manual. New York: Cold Spring Harbor Laboratory, 1986: 241.
33. Hoeffler H, Childers H, Montminy MR, Lechan RM, Goodman RH, Wolde HJ. In situ hybridization methods for detection of somatostatin mRNA in tissue sections using antisense RNA probes. Histochem J 1986: 18: 597.
34. Autio-Harmainen H, Hurskainen T, Niskasaari K, Höyhtyä M, Tryggvason K. Simultaneous expression of 70 kilodalton Type IV collagenase and Type IV collagen alpha-1 (IV) chain genes by cells of early human placenta and gestational endometrium. Lab Invest 1992: 67: 191.
35. Gould VE, Martinez-Lacabe V, Virtanen I, Sahlin KM, Schwartz MM. Differential distribution of tenascin and cellular fibronectins in acute and chronic renal allograft rejection. Lab Invest 1992: 67: 71.
36. Assad L, Schwartz MM, Virtanen I, Gould VE. Immunolocalization of tenascin and cellular fibronectins in diverse glomerulopathies. Virch Arch B Cell Path 1993: 63: 307.
37. Natali PG, Nicotra MR, Bartolazzi A et al. Expression and production of tenascin in benign and malignant lesions of melanocyte lineage. Int J Cancer 1990: 46: 586.
38. Van Duinen CM, Fleuren GJ, Bruijn JA. The extracellular matrix in pigmented skin lesions: an immunohistochemical study. Histopathology 1994: 24: 33.
39. Riedl S, Bodenmuller H, Hinz Ulf et al. Significance of tenascin serum level as tumor marker in primary colorectal carcinoma. Int J Cancer 1995: 64: 65.